AC8 — Auscann group Income Statement
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
Annual income statement for Auscann group, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.862 | 0.389 | 1.82 | 1.64 | 1.87 |
| Cost of Revenue | |||||
| Gross Profit | — | 0.386 | 1.75 | 1.6 | 1.87 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.84 | 7.46 | 12.4 | 26.6 | 12.6 |
| Operating Profit | -6.98 | -7.08 | -10.6 | -24.9 | -10.7 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -7.65 | -7.08 | -10.6 | -24.9 | -10.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.65 | -7.08 | -10.6 | -24.9 | -10.7 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -7.65 | -7.08 | -8.64 | -26.4 | -10.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.65 | -7.08 | -8.64 | -26.4 | -10.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.02 | -0.02 | -0.019 | -0.011 | -0.024 |